KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
603567 HeiLongJiang ZBD Pharmaceutical
- 11.96
- -0.22-1.81%
Market Closed Dec 13 15:00 CST
11.26BMarket Cap17.23P/E (TTM)
12.22High11.95Low138.17KlotVolume12.15Open12.18Pre Close167.18MTurnover1.47%Turnover Ratio23.82P/E (Static)941.14MShares13.6352wk High1.45P/B11.24BFloat Cap8.6952wk Low13.40Limit Up939.54MShs Float58.82Historical High10.96Limit Down2.22%Amplitude8.69Historical Low0.20Dividend TTM12.10Avg Price91.84KlotAsk1.67%Div YieldTTM100Lot Size43.72KlotBid
HeiLongJiang ZBD Pharmaceutical News
Legal Opinion of the 2024 Fourth Extraordinary General Meeting of Shareholders of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 2024 Fourth Extraordinary General Meeting of Shareholders of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on the wholly-owned subsidiary obtaining a drug registration certificate
Meeting materials of the 2024 Fourth Extraordinary General Meeting of Shareholders of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on the intention to change independent directors and adjust the members of the board special committee
Notice of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on convening the 4th Extraordinary General Meeting of Shareholders in 2024
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on progress in providing guarantees for wholly-owned subsidiaries
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on progress in providing guarantees for wholly-owned subsidiaries
Zhenbao Island: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Zhenbao Island: Legal Opinion of the 2024 Third Extraordinary General Meeting of Shareholders of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Legal Opinion of the 2024 Third Extraordinary General Meeting of Shareholders of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Meeting materials of the 2024 Third Extraordinary General Meeting of Shareholders of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on the branch obtaining a notice of approval for the marketing application of chemical raw materials
Notice of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on convening the 3rd Extraordinary General Meeting of Shareholders in 2024
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on the extension of some fund-raising investment projects
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on adding guarantee amounts for wholly-owned subsidiaries
An indicative announcement by Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on the adjustment of the exchange price of non-public exchangeable corporate bonds issued by the controlling shareholder
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on receiving a notice of disapproval of the drug marketing application
Heilongjiang ZBD Pharmaceutical Co., Ltd. Legal Opinion for the Second Extraordinary General Meeting of Shareholders in 2024
